Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,414 GBX | +0.44% | +1.94% | +17.00% |
06:21am | HBM Holdings Unit, AstraZeneca Sign License, Option Agreement for Targeted Cancer Treatment; Shares Rise 16% | MT |
05-22 | Behind the numbers: AstraZeneca aims for sales of $80 billion by 2030 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.00% | 244B | |
+37.74% | 723B | |
+34.62% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+10.03% | 208B | |
-4.17% | 205B | |
+7.43% | 166B | |
+2.81% | 168B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- ASTRAZENECA : Buy rating from JP Morgan